Ronit Satchi-Fainaro insider trades: Teva Pharmaceutical Industries (TEVA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ronit reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | TEVA | ↓ Sell | 415 | $37.25 | $15K | Direct | Aug 25, 2026 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TEVA insiders
Open-market trades in the last 12 months
About Ronit Satchi-Fainaro's insider trades
Ronit Satchi-Fainaro is an insider at Teva Pharmaceutical Industries (TEVA). Since Aug 21, 2026, Ronit has reported no open-market purchases and 1 sale worth $15K on SEC Form 4. In the last 12 months: 1 sale ($15K).
Their filings also include option exercises (8 filings), grants and awards (8 filings), inherited shares (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TEVA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.